Search Results
Baxter to Host 2022 Investor Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill. Chairman and CEO Joe Almeida and other members of Baxter's management team will provide a closer look at the company’s growth strategy, innovation pipeline and longer term financial outlook. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter's pipeline beginning at 8:00 a.m.
Baxter Increases Dividend and Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced an increase in the company's quarterly cash dividend to a rate of $0.29 per share of common stock. This represents an approximately 3.5% increase over the previous quarterly dividend rate of $0.28 per share. Baxter's Board of Directors declared the dividend payable on July 1, 2022, to stockholders of record as of June 3, 2022. The indicated annual dividend rate is now $1.16 per share of common stock.
Baxter Reports First-Quarter 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2022.
Partnering to Empower Health
How Americares partner clinics in the United States are helping low-income, uninsured and underinsured patients address food insecurity and manage their health through technology
Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT). The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the PrisMax or Prismaflex control units (monitors).
Baxter to Host First-Quarter 2022 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2022 financial results on Thursday, April 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.
Responding to Global Water Challenges
How several of our efforts are making an impact around the world
Digital Diagnostics and Baxter Announce New Partnership to Advance Diabetic Retinopathy Detection
Digital Diagnostics and Baxter International Inc. announced a long-term strategic partnership to help front line care providers deliver high-quality care and improve care outcomes. The partnership includes plans to offer Digital Diagnostics’ industry-leading IDx-DR® autonomous AI software as a diagnostic service combined with the Welch Allyn® RetinaVue® 700 Imager.
Baxter Presents Data Indicating Sharesource Increases Patients’ Time on Home Dialysis by More Than Three Months
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management platform with an automated peritoneal dialysis (APD) cycler may improve the clinical effectiveness of home kidney patients care by extending their time on therapy by 3.4 months.
Baxter to Present at Barclays Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays Global Healthcare Conference on Thursday, March 17, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:00 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through September 13, 2022. About Baxter